HEPATOLOGY
ISSN:0270-9139

HEPATOLOGY

HEPATOLOGY
学科领域:医学
是否预警:不在预警名单内
是否OA:
录用周期:约1.0个月
新锐分区:医学1区
年发文量:320
影响因子:16.8
JCR分区:Q1

基本信息

肝脏疾病领域的首要出版物发表原创的、同行评审的文章,涉及肝脏结构、功能和疾病的各个方面。每个月,杰出的编辑委员会都会监督并选择最好的文章,如免疫学、慢性肝炎、病毒性肝炎、肝硬化、遗传和代谢性肝病及其并发症、肝癌和药物代谢。
0270-9139SCIE/Scopus收录
16.8
16.8
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学1区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
1区
N/A
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科:GASTROENTEROLOGY & HEPATOLOGY
SCIE
Q1
7/148
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科:GASTROENTEROLOGY & HEPATOLOGY
SCIE
Q1
6/148
326
320
8%约37.5%约1.0个月-医学-胃肠肝病学
4.2%
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
99.06%20.49%6.67%
CiteScore:29.70
SJR:5.557
SNIP:3.518
学科类别分区排名百分位
大类:Medicine
小类:Hepatology
Q1
5 / 87

期刊高被引文献

A Noncoding Regulatory RNAs Network Driven by Circ‐CDYL Acts Specifically in the Early Stages Hepatocellular Carcinoma
来源期刊:HepatologyDOI:10.1002/hep.30795
Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases
来源期刊:HepatologyDOI:10.1002/hep.31065
Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver Forum
来源期刊:HepatologyDOI:10.1002/hep.30672
Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol-Inducible Cytochrome P450-2E1-Mediated Oxidative and Nitrative Stress.
来源期刊:HepatologyDOI:10.1002/hep.30652
National Experience on Down‐Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha‐Fetoprotein, and Wait Time
来源期刊:HepatologyDOI:10.1002/hep.30879
High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase–Lowering Effect of a HSD17B13 Variant
来源期刊:HepatologyDOI:10.1002/hep.30799
Hippo Signaling Controls NLR Family Pyrin Domain Containing 3 Activation and Governs Immunoregulation of Mesenchymal Stem Cells in Mouse Liver Injury
来源期刊:HepatologyDOI:10.1002/hep.30700
The NACSTOP Trial: A Multicenter, Cluster‐Controlled Trial of Early Cessation of Acetylcysteine in Acetaminophen Overdose
来源期刊:HepatologyDOI:10.1002/hep.30224
An Aging Population of Chronic Hepatitis B With Increasing Comorbidities: A Territory‐Wide Study From 2000 to 2017
来源期刊:HepatologyDOI:10.1002/hep.30833
p53 Up‐regulated Modulator of Apoptosis Induction Mediates Acetaminophen‐Induced Necrosis and Liver Injury in Mice
来源期刊:HepatologyDOI:10.1002/hep.30422
Incidence, Risk Factors, and Outcomes of Transition of Acute Kidney Injury to Chronic Kidney Disease in Cirrhosis: A Prospective Cohort Study
来源期刊:HepatologyDOI:10.1002/hep.30859
Recurrence of Hereditary Hemorrhagic Telangiectasia After Liver Transplantation: Clinical Implications and Physiopathological Insights
来源期刊:HepatologyDOI:10.1002/hep.30424
Liver Transplantation for Acute Liver Failure Due to Dengue Fever
来源期刊:HepatologyDOI:10.1002/hep.30803
Incretin‐Based Therapies for the Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes
来源期刊:HepatologyDOI:10.1002/hep.30670
Methyl‐Sensing Nuclear Receptor Liver Receptor Homolog‐1 Regulates Mitochondrial Function in Mouse Hepatocytes
来源期刊:HepatologyDOI:10.1002/hep.30884
The Use of Human Pluripotent Stem Cells for Modeling Liver Development and Disease
来源期刊:HepatologyDOI:10.1002/hep.30288
Targeting Transforming Growth Factor Beta Signaling in Liver Cancer
来源期刊:HepatologyDOI:10.1002/hep.30426
Primary Biliary Cholangitis in Medicare Population: The Impact on Mortality and Resource Use
来源期刊:HepatologyDOI:10.1002/hep.30174
Incorporating Weight Loss Medications Into Hepatology Practice for Nonalcoholic Steatohepatitis
来源期刊:HepatologyDOI:10.1002/hep.30658
Short‐Duration Pan‐Genotypic Therapy With Glecaprevir/Pibrentasvir for 6 Weeks Among People With Recent Hepatitis C Viral Infection
来源期刊:HepatologyDOI:10.1002/hep.31003
Glial Cell Line–Derived Neurotrophic Factor Enhances Autophagic Flux in Mouse and Rat Hepatocytes and Protects Against Palmitate Lipotoxicity
来源期刊:HepatologyDOI:10.1002/hep.30541
Paracentesis‐Induced Circulatory Dysfunction With Modest‐Volume Paracentesis Is Partly Ameliorated by Albumin Infusion in Acute‐on‐Chronic Liver Failure
来源期刊:HepatologyDOI:10.1002/hep.31071
Letter to the Editor: Defining Acute on Chronic Liver Failure: More Elusive Than Ever
来源期刊:HepatologyDOI:10.1002/hep.30589
Neurological Monitoring in Acute Liver Failure
来源期刊:HepatologyDOI:10.1002/hep.30760
lncRNA PSTAR Promotes p53 Signaling by Inhibiting hnRNP K deSUMOylation and Suppresses Hepatocellular Carcinoma.
来源期刊:HepatologyDOI:10.1002/hep.30793
Letter to Editor: Prognostic Role of Ammonia in Patients With Cirrhosis
来源期刊:HepatologyDOI:10.1002/hep.30758
HCV in Women and Pregnancy
来源期刊:HepatologyDOI:10.1002/hep.30791
Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg‐Positive Children With a Normal Alanine Aminotransferase Level
来源期刊:HepatologyDOI:10.1002/hep.30788
Cirrhotic Cardiomyopathy in Children With Biliary Atresia: A New Objective Parameter to Predict Morbidity and Mortality on the Wait List—and Beyond!
来源期刊:HepatologyDOI:10.1002/hep.30419
Immunosuppression Minimization Trials in Liver Transplantation: Can We Predict Humoral Response to Assess Eligibility?
来源期刊:HepatologyDOI:10.1002/hep.30345
Letter to the Editor: Establishing Reliable Pediatric Percentiles of Serum Liver Enzyme Concentrations Cannot Ignore the Employed Methodology
来源期刊:HepatologyDOI:10.1002/hep.30503
Letter to the Editor: Hepatocellular Carcinoma Surveillance in High‐Risk Patients With Cirrhosis: Contrast‐Enhanced Ultrasound May Be a Choice
来源期刊:HepatologyDOI:10.1002/hep.30819
Letter to the Editor: Statins and Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
来源期刊:HepatologyDOI:10.1002/hep.31080
Reply
来源期刊:HepatologyDOI:10.1002/hep.30639
Reply
来源期刊:HepatologyDOI:10.1002/hep.30536
Letter to Editor: Role of Pharmacotherapy in Patients With Coexisting Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
来源期刊:HepatologyDOI:10.1002/hep.30551
Reply:
来源期刊:HepatologyDOI:10.1002/hep.30796
Reply
来源期刊:HepatologyDOI:10.1002/hep.30545
Fatigue in Primary Biliary Cholangitis: No Place for Rituximab
来源期刊:HepatologyDOI:10.1002/hep.30906
Letter to the Editor: Re: Noninvasive Tests in Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Critical Insights from STELLAR Trials
来源期刊:HepatologyDOI:10.1002/hep.30895
Letter to the Editor: Hypotheses and Assumptions in Mendelian Randomization: Proceed With Caution
来源期刊:HepatologyDOI:10.1002/hep.30599
Letter to the Editor: Liver Transplantation for Acute Liver Failure Because of Dengue Fever: First Successful Reported Case Worldwide
来源期刊:HepatologyDOI:10.1002/hep.30869
Letter to the Editor: Intrahepatic Lipid Content After Insulin Glargine Addition to Metformin in Type II Diabetes Mellitus With Nonalcoholic Fatty Liver Disease
来源期刊:HepatologyDOI:10.1002/hep.30992
Concerns regarding the AARC Study on Corticosteroid therapy for Autoimmune Hepatitis flare causing ACLF.
来源期刊:HepatologyDOI:10.1002/hep.30787
Spontaneous Clearance of Chronic Delta Hepatitis
来源期刊:HepatologyDOI:10.1002/hep.31073
Reply:
来源期刊:HepatologyDOI:10.1002/hep.30619
Reply
来源期刊:HepatologyDOI:10.1002/hep.30287
Letter to the Editor: Suggestions for Rational Management of Nonalcoholic Fatty Liver Disease
来源期刊:HepatologyDOI:10.1002/hep.30797
Reply to Authors:Need to Identify AIH-ACLF as a distinct Entity.
来源期刊:HepatologyDOI:10.1002/hep.30784
Reply
来源期刊:HepatologyDOI:10.1002/hep.30564

相关文章

2026年3月发布(新锐分区)
大类学科小类学科Top期刊综述期刊
医学1区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
1区
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学1区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
1区
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学1区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
1区